Trials / Conditions / Arterial Occlusive Disease

Arterial Occlusive Disease

24 registered clinical trials studyying Arterial Occlusive Disease — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) NCT07023965	Beijing Northland Biotech. Co., Ltd.	—
Withdrawn	Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Su NCT01002209	Karolinska Institutet	Phase 2 / Phase 3
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) NCT04274049	Beijing Northland Biotech. Co., Ltd.	Phase 3
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) NCT04275323	Beijing Northland Biotech. Co., Ltd.	Phase 3
Completed	A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation NCT02685098	Indiana University	Phase 1
Completed	Experimental Study of the Vascular Prosthesis Manufactured by Electrospinning NCT02255188	Meshalkin Research Institute of Pathology of Circulation	—
Completed	BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease NCT02228564	C. R. Bard	N/A
Completed	A Safety and Effectiveness Study of the MD-12-001 Stent in the Treatment of Superficial Femoral Artery or Popl NCT01746550	C. R. Bard	N/A
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia NCT01548378	Beijing Northland Biotech. Co., Ltd.	Phase 2
Completed	Infrapopliteal Drug Eluting Angioplasty Versus Stenting NCT01517997	University of Patras	Phase 2 / Phase 3
Terminated	Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease NCT00913900	University of Wisconsin, Madison	Phase 1
Completed	Angio-Seal Evolution Device Registry NCT00817349	Abbott Medical Devices	—
Terminated	Urokinase Therapy in Patients With Diabetic Foot Syndrome NCT00823225	medac GmbH	Phase 3
Withdrawn	ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion NCT00407940	University of California, San Diego	Phase 4
Terminated	Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia NCT00403780	Karolinska Institutet	Phase 4
Completed	A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography NCT00447889	Guerbet	Phase 4
Completed	Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Pati NCT00189540	AnGes USA, Inc.	Phase 2
Completed	An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Regist NCT00489320	Cordis US Corp.	—
Completed	Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study NCT00673985	C. R. Bard	N/A
Completed	Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries NCT00352222	Boston Scientific Corporation	Phase 3
Completed	ARREST PAD (Peripheral Arterial Disease) NCT00153166	Brigham and Women's Hospital	Phase 2 / Phase 3
Completed	Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia NCT00060892	AnGes USA, Inc.	Phase 2
Completed	Urokinase Therapy in Diabetic Foot Syndrome NCT00537498	medac GmbH	Phase 2
Completed	Imaging of Plaque With Magnetic Resonance Imaging (MRI) NCT00115856	Brigham and Women's Hospital	N/A